Biotech startup Laronde nets $440m Series B round

Biotech startup Laronde has raised $440 million in Series B financing.

Cambridge, Massachusetts-based biotechnology startup Laronde has raised $440 million in Series B financing. The investors included Flagship Pioneering, T. Rowe Price Associates, Inc., Invus, Canada Pension Plan Investment Board, Fidelity Management & Research Company, BlackRock and Federated Hermes Kaufmann Funds.

Source: Press Release